Dr. Michael Ray Holtel, MD

Dr. Holtel practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Holtel's NPI, 1073584397, was assigned on January 27, 2006. Dr. Holtel graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1984. Dr. Holtel holds California license G59182.

Dr. Holtel's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Holtel's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Holtel is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Holtel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holtel practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Holtel's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Holtel is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Holtel is licensed in California.

Dmand AI lists chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, swimmer's ear and thyroid surgery among the conditions Dr. Holtel treats.

CMS data shows 93 Medicare services from Dr. Holtel across 2 procedure codes in 2024, for 118 Medicare patients. Medicare paid $7,399 for them. Every service was in an office.

CMS counts 118 Medicare patients who saw Dr. Holtel in 2024. The largest group is 65 to 74, with 50 patients. 64% of them have high blood pressure, and 63% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Holtel's median patient age at 62, with 56% women.

In 2024, Dr. Holtel wrote 175 Medicare Part D claims for 75 patients. 98% of them were for generic drugs. CMS names the drug for 62 of them, across 3 drugs with 11 or more claims each, at $364 in total drug cost. In 2023, CMS named 52 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Holtel for performance year 2024, reported as part of a group. Dr. Holtel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holtel as offering telehealth. CMS counts 43 procedures of melanoma (skin cancer) excision by Dr. Holtel, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Holtel in 2011. The most frequent topics are Telemedicine, Military Personnel and Otolaryngology. Dr. Holtel has published most often in Laryngoscope. Dr. Holtel's most frequent co-authors are Philip David Littlefield, Jason Redwood Boole, MD and John H. Greinwald, MD.

CMS Open Payments shows 7 general payments to Dr. Holtel from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Cochlear Ltd paid the most, $259.

Dmand AI lists 3 awards for Dr. Holtel.

Dr. Holtel graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1984. Dr. Holtel is a member of NHS and ACS.

Dr. Holtel is in network with 7 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.